Anzeige
Meldung des Tages: Goldchance mit Substanz: Warum dieses Projekt Investoren aufhorchen lässt

ADC Therapeutics Aktie News

Aktie
WKN:  A2PSR8 ISIN:  CH0499880968 US-Symbol:  ADCT Branche:  Biotechnologie Land:  Schweiz
4,11 $
+0,02 $
+0,49%
3,4836 € 19:11:04 Uhr
Depot/Watchlist
Marktkapitalisierung *
295,73 Mio. €
Streubesitz
27,64%
KGV
-1,33
Index-Zuordnung
-

ADC Therapeutics News

27.08.25 - PR Newswire
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 PR Newswire
12.08.25 - PR Newswire
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update PR Newswire
01.08.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
01.07.25 - PR Newswire
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
26.06.25 - PR Newswire
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough? PR Newswire
16.06.25 - PR Newswire
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-​Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant ...
12.06.25 - PR Newswire
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028
ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028 PR Newswire
12.06.25 - PR Newswire
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress
ADC Therapeutics Announces Updated Data from LOTIS-7 Clinical Trial Presented at the European Hematology Association 2025 Congress PR Newswire
02.06.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
15.05.25 - PR Newswire
ADC Therapeutics to Present at Upcoming Investor Conferences
ADC Therapeutics to Present at Upcoming Investor Conferences PR Newswire
14.05.25 - PR Newswire
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update PR Newswire
14.05.25 - PR Newswire
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)
ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International ...
08.05.25 - PR Newswire
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 PR Newswire
28.04.25 - PR Newswire
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025
ADC Therapeutics Announces Preclinical Data Highlighted at the American Association for Cancer Research Annual Meeting 2025 PR Newswire
01.04.25 - PR Newswire
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire
01.04.25 - PR Newswire
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
27.03.25 - PR Newswire
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update PR Newswire
25.03.25 - PR Newswire
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 PR Newswire
20.03.25 - PR Newswire
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025 PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +9,48%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »